Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alteon, Inc.
Geriatrics drug firm reports net loss of $0.17 per share
September 10th, 2003
Alteon, Inc., (ALT) announced a net loss of $5,061,474 for the 3 months ended June 30, 2003. This compares to a net loss of $4,844,205 for the same period in 2002. The net loss applicable to common stockholders, which includes a non-cash preferred stock dividend, was $5,996,181 or $0.17 per share for the 3 months ended June 30, 2003, as compared to $5,703,509 or $0.18 per share for the same period in 2002. Also included in the net loss applicable to common stockholders is non-cash variable stock compensation expense/(benefit) of $531,657 and $(775,206) for the 3 months ended June 30, 2003 and June 30, 2002, respectively, due to fluctuations in our...
Source: Biotech Week (2003-09-10)
|
